CNPAX
Price
$73.77
Change
-$0.11 (-0.15%)
Updated
Jun 22 closing price
Net Assets
171.51B
JEASX
Price
$19.67
Change
+$0.32 (+1.65%)
Updated
Jun 22 closing price
Net Assets
109.22M
Interact to see
Advertisement

CNPAX vs JEASX

CNPAX vs JEASX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. JEASX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and JEASX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 172B vs. JEASX (109M). CNPAX pays higher dividends than JEASX: CNPAX (0.95) vs JEASX (0.00). CNPAX was incepted earlier than JEASX: CNPAX (24 years) vs JEASX (6 years). JEASX (2.92) is less costly to investors than CNPAX (0.74). JEASX is a more actively managed with annual turnover of: 37.00 vs. CNPAX (23.00). JEASX initial investment is less costly to investors than CNPAX (4%) vs CNPAX (4%). CNPAX has a lower initial minimum investment than JEASX: CNPAX (250) vs JEASX (2500). JEASX annual gain was more profitable for investors over the last year : 16.60 vs. CNPAX (13.30). JEASX return over 5 years is better than : 40.79 vs. CNPAX (16.61).
CNPAXJEASXCNPAX / JEASX
Total Expense Ratio0.741.2261%
Annual Report Gross Expense Ratio0.742.9225%
Fund Existence24 years6 years-
Gain YTD6.45012.08053%
Front Load4%6%61%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets172B109M157,798%
Annual Yield % from dividends0.950.00-
Returns for 1 year13.3016.6080%
Returns for 3 years41.5153.6877%
Returns for 5 years16.6140.7941%
Returns for 10 years132.08N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX67.32N/A
N/A
Rydex Biotechnology A
QIACX56.35N/A
N/A
Federated Hermes MDT All Cap Core IS
TGRGX7.44N/A
N/A
Transamerica International Focus I
MBIRX57.22N/A
N/A
Morgan Stanley Insight IR
ARTKX59.27-0.27
-0.45%
Artisan International Value Investor